Invention Grant
- Patent Title: Monoacylglycerol lipase modulators for use in autism spectrum disorders
-
Application No.: US17883210Application Date: 2022-08-08
-
Publication No.: US11974987B2Publication Date: 2024-05-07
- Inventor: Bashkim Kadriu , John A. Moyer , Gahan J. Pandina , Ryan Michael Wyatt
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: A61K31/423
- IPC: A61K31/423 ; A61K31/403 ; A61K31/435 ; A61P25/00
Abstract:
The disclosure relates to certain uses and methods of use of 3.1.0 and 4.1.0 azabicycle compounds of Formula (I), wherein X, Y, R1, R2a, and R2b are defined herein, and pharmaceutical compositions containing them, in the treatment of autism spectrum disorder, including Asperger's syndrome.
Public/Granted literature
- US20230117611A1 MONOACYLGLYCEROL LIPASE MODULATORS FOR USE IN AUTISM SPECTRUM DISORDERS Public/Granted day:2023-04-20
Information query
IPC分类:
